FDA Investigator Laurie P Norwood
Laurie P Norwood has inspections in 6 countries as of 29 Sep 2023. Laurie P Norwood has collaborated with a combinined 2816 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
9
Last Inspection Date:
29 Sep 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
France,
United States of America,
Germany,
United Kingdom of Great Britain and Northern Ireland,
Spain
Co-Investigator(s):
Abdu Alayash,
Andrea A Branche,
Andrea George, PhD,
Angel K Sandhu,
Angela K Shen,
Anh M Lac,
Anissa M Cheung,
Anita R Michael,
Ann L Demarco,
Ann Marie Montemurro,
Barbara J Wilcox, PhD,
Brandon L Mariner,
Burnell M Henry,
Calvin B Koerner,
Carl Lee,
Carole L Jones,
Cassandra Overking,
CDR Donald Ertel,
Christian D Lynch (CDL),
Christopher R Czajka,
Craig D Zagata,
Cynthia Jim, CSO,
Cynthia Kelley,
Daniel C Kearns,
Daniel J Roberts,
David S Cho, PhD,
Destry M Sillivan,
Dino Feigelstock (DF), PhD,
Dmitriy V Volokhov, PhD,
Dr. Gang Wang, PhD,
Dr. Mark J Seaton, PhD,
Dr. Ralph M Bernstein, PhD,
Dr. Willie F Vann, PhD,
Dustin R Abaonza,
Edmund F Mrak, Jr,
Edmund Fmrakjr S,
Eliezar Ramos,
Ellen Huang,
Emily Shacter,
Eric L Dong, BS,
Gene D Arcy,
Gerald Feldman,
Gerald M Feldman, PhD,
Gerald Mierle,
Helen B Ricalde,
Henry K Lau,
Henry X Lau,
J David Doleski,
Jacqueline Mdiaz Albertini,
James A Crim,
James E Keller, PhD,
James M Mason,
James R Evans,
Jeanne Fringer, PhD,
Jeffrey M Watson,
Jennifer L Schmidt,
Joan A Loreng,
Joan T Briones,
John D Finkbohner, PhD,
John F Cipollo,
John M Mcinnis,
Joseph George,
Joseph Kutze, PhD,
Joseph P Iser, MD,
Joshua S Hunt,
Julie D Bringger,
Justin A Boyd,
Karen M Bryerton,
Karen M Cooper,
Kevin P Foley,
Kirsten L Vadheim, PhD,
Kirsten L Vodheim, PhD,
Lakisha M Williams,
Lance M De Souza, MBA,
Larry K Austin,
Laurie B Frazier,
Laurissa S Flowers,
LCDR Jennifer H Rhyu,
Leslie D Wagner,
Lewis K Antwi,
Linda R Kuchenthal,
Linda S Mattingly,
Linda Thai,
Linh Tu,
Lisa M Parsons,
Mabel M Lee,
Maida Henesian (NMI),
Margaret Torres Vazquez,
Marian Majors,
Marie K Kinkade,
Marion Michaelis,
Marion W Nadeau,
Mariza M Jafary,
Mark A Elengold,
Marsha W Major,
Megan A Haggerty,
Michael Shanks, MS,
Michele L Forster, PhD,
Michelle Rfrazier Jessen, PhD,
Mihaly S Ligmond,
Min Shanma Liu,
Nancy L Meade,
Nawab A Siddiqui,
Nayan J Patel,
Nayan Patel,
Nicholas Obiri, PhD,
Nicole K Trudel,
Nikisha M Bolden,
Omatunde O Osunsamni,
Omotunde O Osunsanmi,
Pankaj H Amin,
Paul L Figarole, Jr,
Paula A Trost,
Peter E Baker,
Peter Kessler, PhD,
Prabhu P Raju,
Raymond T Oji,
Rebecca K Olin,
Rebecca Rodriguez,
Rebecca T Davis,
Richard W Thornton,
Riley C Myers, PhD,
Robert D Tollefsen,
Robert Sausville,
Robert W Jennings,
Robin Levis, PhD,
Rose Ashley,
Rose M Ashley,
Sandra S Saniga,
Sarah B Tanksley,
Scott E Norris,
Scott N Lim,
Sean R Bryd,
Serge Beaucage,
Shelley H Beausoleil,
Sherri J Jackson,
Sidney B Priesmeyer,
Solomon Yimam (SY),
Sonya M Edmonds,
Stephanie A Slater, MS,
Steven A Rubin,
Stuart W Russell,
Susan F Laska, MS,
Susan M Jackson,
Susan Yu,
Thea C Grome,
Thuy T Nguyen, LCDR,
Tim Lee,
Timothy C Grome,
Tina S Roecklein,
Travis S Bradley,
Truong Xuan Nguyen (Andy),
Wanda Y Honeyblue,
Wei Wang, PhD,
William V Millar,
Yasamin Ameri,
Yi Wang, PhD,
Yiping Jia
Laurie P Norwood's Documents
| Publish Date | Document Type | Title |
|---|---|---|
| March, 2001 | FDA 483 Response | Seqirus Vaccines Limited - Form 483R, 2001-04-20 |
| January, 2000 | EIR | Genentech, Inc. - EIR, 2000-01-14 |
| March, 2005 | FDA 483 | Sanofi Pasteur Inc. - Form 483, 2005-03-18 |
| May, 2014 | EIR | GSK Vaccines GmbH - EIR, 2014-05-06 |
| January, 2000 | FDA 483 | Genentech, Inc. - Form 483, 2000-01-14 |
| March, 2001 | EIR | Seqirus Vaccines Limited - EIR, 2001-04-30 |
| March, 2003 | FDA 483 | Biopure Corporation - Form 483, 2003-03-27 |
| March, 2001 | FDA 483 Response | Seqirus Vaccines Limited - Form 483R, 2001-04-20 |
| March, 2001 | FDA 483 | Evans Vaccines Ltd. - Form 483, 2001-03-09 |
| May, 2014 | FDA 483 | GSK Vaccines GmbH - Form 483, 2014-05-06 |
| October, 2003 | FDA 483 | Wyeth Farma SA - Form 483, 2003-10-29 |
Experience Redica System's NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more